Venture Capital Activity Moderates as U.S. Startups Secure Slower Week of Funding
Venture capital investors scaled back on giant financing rounds over the past week, with only two startup deals clearing the multiple hundreds of millions threshold. Despite the slight cooling off in overall mega-round sizes, emerging companies across artificial intelligence, construction technology, and biotechnology still managed to attract significant capital from prominent venture firms.
Top Funding Rounds Highlighted by Infrastructure and Tech
The largest transaction of the week went to Modal Labs, a cloud infrastructure provider focused on AI inference and other applications. The New York-based enterprise secured $750 million in a Series D financing round led by Accel, pushing its valuation to $15.75 billion. The company reported surpassing an annual revenue run rate of $1 billion prior to the announcement.
Construction automation unicorn Icon also captured substantial interest, closing on $200 million in Series D funding. Led by Baillie Gifford and BlackRock, the Austin-based developer of robotic construction systems and 3D-printed homes anticipates quadrupling its revenue growth in 2026.
Biotech and Specialized Sectors Draw Capital
Beyond artificial intelligence and construction technology, several companies in life sciences and specialty insurance successfully closed notable funding rounds:
- Soufflé Therapeutics raised $135 million in Series B financing for its RNA therapies development.
- Estuary Biotherapeutics launched with $103 million in total financing, including a Series A round led by RA Capital Management.
- Stand secured $70 million in Series C funding at a $1 billion valuation to support its insurance offerings for homes in high-risk natural disaster zones.
The weekly market data illustrates a measured approach by institutional investors, prioritizing established market players and high-growth sectors even as mega-deal volumes experience temporary contraction.
